The Role of High-flow Nasal Cannula Therapy in the Treatment of Acute Carbon Monoxide Poisoning

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The aim of the study is to test whether oxygen therapy delivered through high‐flow nasal cannula devices in patients admitted to the emergency department for acute carbon monoxide poisoning is superior to the non‐rebreathing oxygen face mask therapy with a 15 L/minute oxygen flow (currently the first‐line therapy), in terms of reduction of carboxyhemoglobin (COHb) concentration and delayed neurological sequelae incidence.
Epistemonikos ID: 17dbdabf7dbb4c02b6fc664414e4ce47d9103e4f
First added on: May 21, 2024